Cargando…

Using protein microarray technology to screen anti-ERCC1 monoclonal antibodies for specificity and applications in pathology

BACKGROUND: An antibody with cross-reactivity can create unexpected side effects or false diagnostic reports if used for clinical purposes. ERCC1 is being explored as a predictive diagnostic biomarker for cisplatin-based chemotherapy. High ERCC1 expression is linked to drug resistance on cisplatin-b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Donghui, Baruch, Dror, Shu, Youmin, Yuan, Kehu, Sun, Zairen, Ma, Kaiyan, Hoang, Toan, Fu, Wei, Min, Li, Lan, Zhu-Sheng, Wang, Fangxun, Mull, Lori, He, Wei-Wu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526464/ https://www.ncbi.nlm.nih.gov/pubmed/23171216 http://dx.doi.org/10.1186/1472-6750-12-88

Ejemplares similares

The Association of ERCC1 and ERCC5 Polymorphisms with Lung Cancer Risk in Han Chinese
por: Lan, Xueling, et al.
Publicado: (2022)

ERCC1 and ERCC2 Variants Predict Survival in Gastric Cancer Patients
por: Li, Yangkai, et al.
Publicado: (2013)

Association of ERCC1 rs3212986 & ERCC2 rs13181 polymorphisms with the risk of glioma
por: Cui, Qing-ke, et al.
Publicado: (2014)

Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population
por: Ni, Min, et al.
Publicado: (2014)

ERCC6L2‐associated inherited bone marrow failure syndrome
por: Shabanova, Iren, et al.
Publicado: (2018)

ERCC2, ERCC1 polymorphisms and haplotypes, cooking oil fume and lung adenocarcinoma risk in Chinese non-smoking females
por: Yin, Zhihua, et al.
Publicado: (2009)

Analysis of ERCC1 and ERCC2 gene variants in osteosarcoma, colorectal and breast cancer
por: GÓMEZ-DÍAZ, BENJAMÍN, et al.
Publicado: (2015)

MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells
por: Xie, Xiaoque, et al.
Publicado: (2019)

The use of microarray technologies in clinical oncology
por: Gabriele, L, et al.
Publicado: (2006)

The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development
por: Rouissi, Kamel, et al.
Publicado: (2011)

Epistatic SNP interaction of ERCC6 with ERCC8 and their joint protein expression contribute to gastric cancer/atrophic gastritis risk
por: Jing, Jing-Jing, et al.
Publicado: (2017)

ERCC1 and ERCC2 Haplotype Modulates Induced BPDE-DNA Adducts in Primary Cultured Lymphocytes
por: Lu, Xiaobo, et al.
Publicado: (2013)

The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients
por: Obiedat, Hadeel, et al.
Publicado: (2018)

Polymorphisms in ERCC2 and ERCC5 and Risk of Prostate Cancer: A Meta-Analysis and Systematic Review
por: Liu, Yi, et al.
Publicado: (2018)

Integrative genomic analysis implicates ERCC6 and its interaction with ERCC8 in susceptibility to breast cancer
por: Moslehi, Roxana, et al.
Publicado: (2020)

Associations of individual and joint expressions of ERCC6 and ERCC8 with clinicopathological parameters and prognosis of gastric cancer
por: Chen, Jing, et al.
Publicado: (2021)

Association of ERCC5 Genetic Polymorphisms With Cirrhosis and Liver Cancer
por: Yang, Gang, et al.
Publicado: (2020)

Meta-analysis showing that ERCC1 polymorphism is predictive of osteosarcoma prognosis
por: Liu, Xueyong, et al.
Publicado: (2017)

ERCC1 polymorphism and its expression associated with ischemic stroke in Chinese population
por: Deng, Xiao-Dong, et al.
Publicado: (2023)

Automated ERCC1 immunochemistry on hybrid cytology/tissue microarray of malignant effusions: evaluation of antibodies 8F1 and D-10
por: Soltermann, Alex, et al.
Publicado: (2011)

Nucleotide Excision Repair Gene ERCC2 and ERCC5 Variants Increase Risk of Uterine Cervical Cancer
por: Joo, Jungnam, et al.
Publicado: (2016)

Polymorphisms in ERCC4 and ERCC5 and risk of cancers: Systematic research synopsis, meta-analysis, and epidemiological evidence
por: Zuo, Chunjian, et al.
Publicado: (2022)

Protein microarray technology
por: Hall, David A., et al.
Publicado: (2007)

Development of an antigen microarray for high throughput monoclonal antibody selection
por: Staudt, Nicole, et al.
Publicado: (2014)

Clinical Perspectives of ERCC1 in Bladder Cancer
por: Koutsoukos, Konstantinos, et al.
Publicado: (2020)

Association of ERCC gene polymorphism with osteosarcoma risk
por: Wang, Guanliang, et al.
Publicado: (2020)

The expression of ERCC1 and BRCA1 predicts prognosis of platinum-based chemotherapy in urothelial cancer
por: Song, Wenhui, et al.
Publicado: (2016)

A pathway sensor for genome-wide screens of intracellular proteolytic cleavage
por: Ketteler, Robin, et al.
Publicado: (2008)

Genetic polymorphisms of ERCC-1 and ERCC-2 are not prognostic markers in osteosarcoma patients with chemotherapy: A meta-analysis in Chinese population
por: Liu, Dabiao, et al.
Publicado: (2018)

Association Between ERCC1 rs3212986 and ERCC2/XPD rs1799793 and OS in Patients With Advanced Esophageal Cancer
por: Boldrin, Elisa, et al.
Publicado: (2019)

Expression of ERCC1 and TYMS in colorectal cancer patients and the predictive value of chemotherapy efficacy
por: Jiang, Hong, et al.
Publicado: (2019)

Functional protein microarray technology
por: Hu, Shaohui, et al.
Publicado: (2011)

The microarray technology: facts and controversies
por: Lévêque, N., et al.
Publicado: (2012)

Association of ERCC1 C8092A and ERCC2 Lys751Gln Polymorphisms with the Risk of Glioma: A Meta-Analysis
por: Xin, Yu, et al.
Publicado: (2014)

Genetic polymorphisms and haplotypes of ERCC1 and ERCC2 associated with quality of life, depression, and anxiety status among patients with lung cancer
por: Tang, Yunxiang, et al.
Publicado: (2021)

Novel ERCC2 variant in trichothiodystrophy infant: the first case report in China
por: Chen, Jian-Dong, et al.
Publicado: (2021)

The AKT/GSK3β-Mediated Slug Expression Contributes to Oxaliplatin Resistance in Colorectal Cancer via Upregulation of ERCC1
por: Wei, Wei, et al.
Publicado: (2020)

The ERCC6 Gene and Age-Related Macular Degeneration
por: Baas, Dominique C., et al.
Publicado: (2010)

XPF–ERCC1: Linchpin of DNA crosslink repair
por: McHugh, Peter J.
Publicado: (2020)

Are race-specific ERCC1 haplotypes in melanoma cases versus controls related to the predictive and prognostic value of ERCC1 N118N?
por: Gao, Rui, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_o2bo2hqq600jsa6vmnttilv7ts